Log in
Enquire now
‌

US Patent 9339221 Diagnosing intestinal ischemia based on oxygen saturation measurements

Patent 9339221 was granted and assigned to Vioptix, Inc. on May, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
‌
Vioptix, Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9339221
Date of Patent
May 17, 2016
Patent Application Number
12410007
Date Filed
March 24, 2009
Patent Citations Received
‌
US Patent 11864878 Devices and methods for determining blood flow around a body lumen
0
‌
US Patent 11903704 Oximetry device with laparoscopic extension
0
‌
US Patent 12076109 Using an oximeter probe to detect intestinal ischemia
0
Patent Primary Examiner
‌
Sean Dougherty
Patent abstract

Devices and systems have a sensor probe configured to measure tissue oxygen saturation in the intestine or mesentery. The devices and systems can determine the oxygenation state of the entire thickness of the intestine or mesentery. Thus, embodiments of the invention can be applied in diagnosing intestinal ischemia in a patient, as well as in monitoring tissue oxygen saturation of the intestine or mesentery during or after a surgical procedure.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9339221 Diagnosing intestinal ischemia based on oxygen saturation measurements

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.